Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew Lennard

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|August 15, 2023
Compliance and regulatory considerations for the implementation of the multi-attribute-method by mass spectrometry in a quality control laboratoryAnnick Gervais, Eef H C Dirksen, Thomas Pohl, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|May 5, 2023
Technical considerations for the implementation of the multi-attribute-method by mass spectrometry in a quality control laboratoryThomas Pohl, Annick Gervais, Eef H C Dirksen, et al.
The AAPS Journal|September 16, 2021
Considerations for Updates to ICH Q1 and Q5C Stability Guidelines: Embracing Current Technology and Risk Assessment StrategiesMegan E McMahon, Alexander Abbott, Yelizaveta Babayan, et al.
The AAPS Journal|November 16, 2021
Correction to: Considerations for Updates to ICH Q1 and Q5C Stability Guidelines: Embracing Current Technology and Risk Assessment StrategiesMegan E McMahon, Alexander Abbott, Yelizaveta Babayan, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|August 15, 2023
Compliance and regulatory considerations for the implementation of the multi-attribute-method by mass spectrometry in a quality control laboratoryAnnick Gervais, Eef H C Dirksen, Thomas Pohl, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|May 5, 2023
Technical considerations for the implementation of the multi-attribute-method by mass spectrometry in a quality control laboratoryThomas Pohl, Annick Gervais, Eef H C Dirksen, et al.
The AAPS Journal|September 16, 2021
Considerations for Updates to ICH Q1 and Q5C Stability Guidelines: Embracing Current Technology and Risk Assessment StrategiesMegan E McMahon, Alexander Abbott, Yelizaveta Babayan, et al.
The AAPS Journal|November 16, 2021
Correction to: Considerations for Updates to ICH Q1 and Q5C Stability Guidelines: Embracing Current Technology and Risk Assessment StrategiesMegan E McMahon, Alexander Abbott, Yelizaveta Babayan, et al.
Pageof 2